The global computer aided drug discovery market is anticipated to grow at a CAGR of 11.5% during the forecast period. Rising drug discovery and development activities owing to the rising prevalence of infectious and chronic diseases is contributing to the growth of the global computer-aided drug discovery market. Several partnerships for drug discovery and development have been witnessed over the years, which in turn, is boosting the market growth.
Browse the full report description of “Computer-Aided Drug Discovery Market Size, Share & Trends Analysis Report, By Type (Structure-Based Drug Design, Ligand-Based Drug Design, and Sequence-Based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, and Diabetes) By End-User (Pharmaceutical Companies, Biotechnology Companies, and Research Laboratories), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/computer-aided-drug-discovery-market
Recent Partnerships for Drug Discovery
• September 2021- Huadong Medicine and Insilico Medicine entered into a co-development agreement to accelerate the discovery of breakthrough small-molecule therapeutics by leveraging an innovative approach in the oncology field. Under the collaboration, Insilico and Huadong Medicines launched a new drug discovery project involving the R&D team of both parties. The collaboration will leverage Huadong Medicine’s advanced innovative drug discovery in combination with Insilico’s end-to-end AI-driven rug discovery platform. The project leads to hit undruggable targets that regulate tumor growth.
• May 2022- SOM biotech announced that it has signed a licensing agreement with the Ministry of Minnesota. With this collaboration, the University of Minnesota conducted a series of in vitro studies on potential pre-clinical product candidates for Duchenne and Becker muscular dystrophy identified using SOM Biotech’s exclusive platform, SOMAIPRO. Somaipro assists in identifying drugs effective for the treatment of a specific disease, discovering new mechanisms of action and new applications for a drug, and predicting the toxicity of the compounds, as well as the molecular scaffolds for compounds active on a given target. While other AI-based approaches use methods based on data mining, structural similarity, or the target structure, SOMAIPRO uses molecular fields, allowing for an increased rate of success, with results achieved in the shortest possible time and considerably reducing the costs associated with drug discovery.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered- by type, by therapeutic area, by end user
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- F-Hoffman-La Roche Ltd., Bayer AG, Charles River Laboratories International Inc., Laboratory Corporation of America Holdings (Labcorp), and Schrödinger, Inc.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Computer-Aided Drug Discovery Market Report by Segment
By Type
By Therapeutic Area
By End-User
Global Computer-Aided Drug Discovery Market Report by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/computer-aided-drug-discovery-market